Anti-CD40 antibody formulation
作者： Claudia Mueller , Matthias Willmann
DOI:
关键词:
摘要: Anti-CD40 antibodies are formulated as lyophilizate or liquid formulation. The lyophilizates can be reconstituted to give a solution with high concentration of the antibody active ingredient for delivery patient without levels aggregation. an aqueous reconstituent provide composition in which has at least 50 mg/ml. pharmaceutical may include one more sugar, buffering agent, surfactant, and/or free amino acid.
lens.org 参考文章(21)
Mohammad Luqman, Sharon Lea Aukerman, Bahija Jallal, Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease ,(2006)
Bei Chen, Michael G. Mulkerrin, Steven M Chamow, Gerardo Zapata, System and method for stabilizing antibodies with histidine ,(2003)
Hans Hofer, Peter Schroeder, Michael Tschope, Thomas Siklosi, Liquid interferon-beta formulations ,(1998)
Mohammad Luqman, Sharon Lea Aukerman, Uses of anti-cd40 antibodies ,(2006)
Sanjeev Mariathasan, Heather Maecker, Bryan Irving, Henry Chiu, Jeanne Cheung, Yan Wu, Sophie M. Lehar, Anti-pd-l1 antibodies and their use to enhance t-cell function ,(2009)
Kidisti Araya, Augustus Okhamafe, Bao-Lu Chen, Xiaofeng Lu, Antagonist anti-cd40 antibody pharmaceutical compositions ,(2007)
Isabel Zaror, Mohammad Luqman, Li Long, Sang Hoon Lee, Deborah Hurst, Asha Yabannavar, Bao-Lu Chen, Xiaofeng Lu, Antagonist anti-cd40 monoclonal antibodies and methods for their use ,(2004)
Thomas Siklosi, Hans Hofer, Peter Schroeder, Michael Tschope, Liquid interferon-β formulations ,(1998)
Hanno Richards, Matthias Machacek, Shephard Mpofu, Karthinathan Thangavelu, Methods of treating rheumatoid arthritis using il-17 antagonists ,(2011)
Daniel B. Dix, Xiaolin Tang, Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies ,(2011)